Phase
Condition
Congestive Heart Failure
Hyponatremia
Chest Pain
Treatment
N/AClinical Study ID
Ages 45-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female participants aged 45 to 80 years (inclusive) at the date of signingthe informed consent.
Diagnosed with heart failure.
Able and willing to provide informed consent to participate.
Exclusion
Exclusion Criteria:
Diagnostic test results positive for:
HIV-1 or HIV-2 infection
Hepatitis B or Hepatitis C infection
Mental incapacity, language barriers or unwillingness to comply with therequirements of the protocol, which may preclude adequate understanding orcooperation during the study as judged by the Investigator.
Any condition judged by the Investigator to pose an undue risk while participatingin the trial
Diagnostic results which are inconsistent with heart failure with mildly reduced orpreserved ejection fraction as judged by the Investigator.
Study Design
Study Description
Connect with a study center
Richmond Pharmacology
London, SE1 1YR
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.